bioRxiv Science⌕ Search

Biology subjects

Scroggins, D. G.

Publications and source records attributed to Scroggins, D. G..

2 recordsLinked to original sources

Regulator of G-Protein Signaling 2 Knockout in CD4+ T Cells Promotes Anti-Inflammatory T Cells, Enhancing Ovulation, and Oocyte Yield

Structured AbstractO_ST_ABSObjectiveC_ST_ABSTo determine the downstream effects on ovarian function and immune cell differentiation in the ovary and uterus using a model in which RGS2 was knocked out specifically in CD4+ T cells. DesignLaboratory based experiments with female mice. AnimalsFemale congenic (fully backcrossed) and non-congenic (mixed strain) mice with CD4 T cell-specific RGS2 knockout. ExposureFour-week-old female CD4 RGS2 knockout (CD4 RGS2KO) mice and their littermate controls (CD4 RGS2CTL) were subjected to superovulation using pregnant mare serum gonadotropins. Main Outcome MeasuresOocyte numbers, lymphocyte populations in the ovary and uterus, and serum estradiol and progesterone concentrations. ResultIn non-congenic (mixed strain) mice, CD4 RGS2 knockout (KO) promoted higher oocyte ovulation and increased uterine total leukocyte numbers. Similarly, congenic (fully backcrossed strain) mice showed higher oocyte numbers and increased uterine total leukocytes in the CD4 RGS2KO mice compared to CD4 RGS2CTL mice. Pro-inflammatory CD4+ T helper (TH) 1 and TH17 cell frequencies in the ovary and uterus were unchanged, while Treg and TH2 cell frequencies were elevated, along with increased concentrations of estradiol and progesterone in the serum of CD4 RGS2KO mice. ConclusionOur study highlights the important role of RGS2 in CD4+ T cells within the context of reproduction. The dysregulation of immune responses due to RGS2 knockout in CD4+ T cells appears to enhance oocyte production. Further research is warranted to elucidate the precise mechanisms by which RGS2 influences reproductive outcomes, including its impact on fecundability, endometrial receptivity, and successful implantation.

immunology↗

Cellular Immunotherapy in Mice Prevents Maternal Hyperten-sion and Restores Anti-Inflammatory Cytokine Balance in Ma-ternal and Fetal Tissues

Preeclampsia is the leading cause of maternal-fetal morbidity world-wide. The concept that persistent feto-placental intolerance is important in the pathogenesis of preeclampsia (PreE) has been demonstrated by our lab and others. Arginine vasopressin (AVP) infusion during pregnancy induces cardiovascular, renal, and T helper (TO_SCPLOWHC_SCPLOW) cell alterations in mice consistent with human PreE. In addition to their conventional immuno-stimulatory role, dendritic cells (DCs) also play a vital role in immune tolerance. In contrast to conventional DCs, regulatory DCs (DCregs) express low levels of co-stimulatory markers, produce anti-inflammatory cytokines, induce T regulatory (Treg) cells, and promote tolerance. In mice, DCregs prevent pro-inflammatory responses and induce antigen-specific tolerance. Given these known functions of DCregs, we hypothesize that DCregs will prevent the development of AVP-induced PreE in mice. C57BL/6J females were infused with AVP (24 ng/hour) or saline throughout gestation via osmotic minipump. Bone marrow derived DCregs were injected into AVP-infused dams at the time of pump implantation or on gestational day (GD) 7. Blood pressure was taken throughout pregnancy. Maternal urine protein and TH-associated cytokines in maternal and fetal tissues were measured on GD 18. Treatment with DCregs effectively prevented the elevation of maternal blood pressure, proteinuria, and fetal growth restriction that was observed in AVP-infused dams. Furthermore, we noted a reduction in pro-inflammatory TH-associated cytokines IFN{gamma} and IL-17, while anti-inflammatory cytokines IL-4, IL-10, and TGF{beta} showed an increase following DCreg treatment. These outcomes provide strong evidence supporting the potential of DCregs as a valuable therapeutic approach in addressing PreE.

immunology↗